● The company's profit outlook over the next few years is a strong asset.
● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
● Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 32.5 times its estimated earnings per share for the ongoing year.
● The company appears highly valued given the size of its balance sheet.
● The company is not the most generous with respect to shareholders' compensation.
● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.